Eperezolid
Eperezolid is a synthetic antibiotic that belongs to the oxazolidinone class of drugs. It was developed by Pharmacia and is a second-generation oxazolidinone, following the first-generation drug, linezolid.
Chemistry[edit | edit source]
Eperezolid is a synthetic compound that is structurally related to linezolid. Both drugs are part of the oxazolidinone class, which is characterized by a 1,3-oxazolidin-2-one core structure. The chemical formula of eperezolid is C16H20FN3O4.
Mechanism of Action[edit | edit source]
The mechanism of action of eperezolid is similar to that of other oxazolidinones. It inhibits protein synthesis in bacteria by binding to the 50S subunit of the bacterial ribosome. This prevents the formation of a functional 70S initiation complex, which is essential for the translational process in bacteria.
Clinical Use[edit | edit source]
Eperezolid was developed for the treatment of infections caused by Gram-positive bacteria, including those resistant to other antibiotics. However, it has not been as widely used as linezolid, primarily due to concerns about its potential for toxicity.
Safety and Efficacy[edit | edit source]
In clinical trials, eperezolid has been shown to be effective against a variety of Gram-positive bacteria. However, its use has been limited by concerns about potential side effects, including thrombocytopenia, anemia, and neuropathy. These side effects are believed to be related to the drug's mechanism of action and its effect on mitochondrial protein synthesis.
Development and Approval[edit | edit source]
Eperezolid was developed by Pharmacia, which later became part of Pfizer. It was one of the first oxazolidinones to be developed and was initially seen as a promising new class of antibiotics. However, its development was overshadowed by the success of linezolid, which was approved by the Food and Drug Administration (FDA) in 2000.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
